Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution von López, L., Garrido Onecha, M.A.L., Távara, B., Pérez, S.L., Vázquez, M., Medina, S., Castanón, C., López, A., García Palomo, A.S., Rodríguez Sánchez, N.

Volltext

P241 - Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution von López, L., Garrido Onecha, M.A.L., Távara, B., Pérez, S.L., Vázquez, M., Medina, S., Castanón, C., López, A., García Palomo, A.S., Rodríguez Sánchez, N.

Volltext

P174 Tivozanib in first-line treatment of metastatic renal cell carcinoma. Experience in our institution von López, L., Sánchez Cousido, L.F., Garrido Onecha, M.A.L., Vázquez Díez, M., Pérez, S., Aguilar Borasteros, V., Távara Silva, B., Pedraza Lorenzo, M., Medina Valdivieso, S., García Palomo, A.S., Rodríguez Sánchez, A.

Volltext